Graves' disease: vizsgálatok itt: Franciaország
2 of 4 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisVisszavonvaA Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
- Where
- Angers, Bron, Nantes, Paris
- Életkor
- 18 év and over
- People
- 230 worldwide
- Run by
- argenx
See details and how to joinNCT07596849 · EU 2025-523333-26-00 - No phaseNot yet taking people in FranciaországProspective Evaluation of OptiThyDose
- Where
- Paris
- Életkor
- Up to 18 év
- People
- 150 worldwide
- Run by
- University Children's Hospital Basel
See details and how to joinNCT06864351